User:Rupertdonovan/sandbox
John Stuelpnagel | |
|---|---|
| Born | John R. Stuelpnagel |
| Nationality | American |
| Alma mater | University of California, Davis (B.S) (D.V.M.) UCLA Anderson School of Management (MBA) |
| Occupation(s) | Founder and CEO of Illumina, Inc. (1998 - 2009) Chairman and Co-founder of Fabric Genomics (2009 - Present) Chairman of 10x Genomics (2013 - Present) |
| Website | fabricgenomics |
John R. Stuelpnagel is an American venture capitalist, inventor, medical researcher and publicist, specializing in biotechnology.[1][2][3] He is mostly known for business and research contributions to DNA sequencing technology through co-founding Illumina, Inc.,[4][5] a company that helped to reduce the cost of sequencing a human genome.[6][7][8] Stuelpnagel has also co-founded and ran multiple early-stage growth companies related to biotechnologies or genomics.[9][10] Stuelpnagel holds 35 issued U.S. patents.[6][11]
- ^ "The future of next-gen sequencing (and why an Illumina cofounder's never had his genome mapped)". MedCityNews.
- ^ "Eight Lessons from John Stuelpnagel (Illumina)". Medium.
- ^ "Illumina's original people are coming soon, and the mysterious Chu CHUANG, who is at the helm of the Chinese executives, has attracted $400 million in 4 years to build a cheaper DNA sequencer". MinNews.
- ^ "Illumina- The Origin story". www.linkedin.com.
- ^ "Illumina: Cheap With Further Upside From Grail". Seeking Alpha.
- ^ a b "2017 Alumni Achievement Award Recipients". UC Davis Veterinary Medicine.
- ^ "Illumina-Maintaining Growth Momentum in a Plateauing Genome Sequencing Market". IBS Center for Management Research: 18. 2017.
- ^ "Illumina's CEO on the Promise of the $1,000 Genome -- And the Work That Remains". Recode. March 25, 2014.
- ^ "John R. Stuelpnagel, Chairman, 10X Genomics, Inc". Wall Street Journal Markets.
- ^ "John Stuelpnagel". MarketScreener.
- ^ "Patents by Inventor John R. Stuelpnagel". Justia Patents.